Le Lézard
Classified in: Business
Subject: BOARD OF DIRECTORS

United Fire Group, Inc. Reports on Annual Meeting of Shareholders


Director Elections to the Board of Directors

CEDAR RAPIDS, Iowa, May 18, 2018 (GLOBE NEWSWIRE) -- United Fire Group, Inc. (Nasdaq:UFCS) (the "Company" or "UFG") announced today that shareholders elected four Class C Directors to our 12-member board at the 2018 Annual Meeting of Shareholders held on May 16, 2018.

The following individuals were each elected to serve three-year terms expiring in 2021:

In other official business, our shareholders:

New Officer Elections

The Company is pleased to announce the following officer elections effective May 16, 2018:

Michael J. Sheeley
United Fire & Casualty Company elected Corporate Marketing Director Michael J. Sheeley as a Vice President. His new title is VP?Corporate Marketing.

Robert F. Cataldo
United Fire & Casualty Company elected AVP & Senior Portfolio Manager Robert F. Cataldo as a Vice President. His new title is VP & Strategy Officer.

Adam R. Brown
United Fire & Casualty Company elected Corporate Director of Claims Administration Adam R. Brown as an Assistant Vice President. His new title is AVP?Corporate Claims Administration.

Michael D. Enz
United Fire & Casualty Company elected Marketing Manager Michael D. Enz as an Assistant Vice President. His new title is AVP?East Coast Marketing.

Matthew G. Schleier
United Fire & Casualty Company elected Regional Marketing Manager Matthew G. Schleier as an Assistant Vice President. His new title is AVP?Midwest Marketing.

Jordan A. Sherry
United Fire & Casualty Company elected Regional Marketing Manager Jordan A. Sherry as an Assistant Vice President. His new title is AVP?Rocky Mountain Marketing.

About UFG?Founded in 1946 as United Fire & Casualty Company, UFG, through its insurance company subsidiaries, is engaged in the business of writing property and casualty insurance.

Through our subsidiaries, we are licensed as a property and casualty insurer in 46 states, plus the District of Columbia, and we are represented by approximately 1,150 independent agencies. A.M. Best Company assigns a rating of "A" (Excellent) for members of the United Fire & Casualty Group.

For more information about UFG, visit www.ufginsurance.com.

Contact?Randy Patten, AVP of Finance and Investor Relations, 319-286-2537 or [email protected].

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/5ca8860f-5a0e-4dd6-9856-691ea26b4b77

http://www.globenewswire.com/NewsRoom/AttachmentNg/5646da36-6729-4fb9-ba8f-8ac2d156b768

http://www.globenewswire.com/NewsRoom/AttachmentNg/8b1f3df5-acd7-4014-9064-f2a88aede1a5

http://www.globenewswire.com/NewsRoom/AttachmentNg/cb4f1590-01a5-4678-9f37-cf43407450ec

http://www.globenewswire.com/NewsRoom/AttachmentNg/5ca8860f-5a0e-4dd6-9856-691ea26b4b77

http://www.globenewswire.com/NewsRoom/AttachmentNg/9b1c1825-2bc5-49b6-86ae-8ccadaa29b00


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: